New insights into development and mortality of <scp>COVID‐19</scp>‐associated pulmonary aspergillosis in a homogenous cohort of 1161 intensive care patients

Abstract

We observed a low but likely underestimated prevalence of CAPA in our study. CAPA is a disease with high mortality and diabetes is a significant factor for its development while ARDS and pulse glucocorticoid treatment are significant factors for its mortality. Cellular immune dysregulation may have a central role in CAPA from its development to mortality.

References

Page 1

	Year	Citations
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study Nanshan Chen, Min Zhou, Xuan Dong, The Lancet Descriptive StudyVirus EpidemiologyRespiratory DiseasesMedicineCovid-19 Pandemic	2020	22.5K
Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study Carolina García‐Vidal, Gemma Sanjuan, Estela Moreno-García, Clinical Microbiology and Infection Infectious Disease EpidemiologyRetrospective Cohort StudyHealthcare-associated InfectionClinical EpidemiologyCovid-19 Pandemic	2020	1K
COVID‐19 associated pulmonary aspergillosis Philipp Koehler, Oliver A. Cornely, Bernd W. Böttiger, Mycoses	2020	534
Epidemiology of Invasive Pulmonary Aspergillosis Among Intubated Patients With COVID-19: A Prospective Study Michele Bartoletti, Renato Pascale, Monica Cricca, Clinical Infectious Diseases	2020	477
Fungal infections in mechanically ventilated patients with COVID-19 during the first wave: the French multicentre MYCOVID study The Lancet Respiratory Medicine Respiratory DiseasesCovid-19 PandemicFungal InfectionsRespiratory InfectionVentilated Patients	2021	269
COVID-19–Associated Pulmonary Aspergillosis, March–August 2020 Jon Salmanton‐García, Rosanne Sprute, Jannik Stemler, Emerging infectious diseases Intensive Care UnitClinical Infectious DiseaseEmerging Infectious DiseasesRespiratory DiseasesCumulative Incidence	2021	254
Tocilizumab plus standard care versus standard care in patients in India with moderate to severe COVID-19-associated cytokine release syndrome (COVINTOC): an open-label, multicentre, randomised, controlled, phase 3 trial Arvinder S. Soin, Kuldeep Kumar, Narendra S. Choudhary, The Lancet Respiratory Medicine	2021	232
Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients—a multinational observational study by the European Confederation of Medical Mycology Juergen Prattes, Joost Wauters, Daniele Roberto Giacobbe, Clinical Microbiology and Infection	2021	219
Hydrocortisone-enhanced growth of Aspergillus spp.: implications for pathogenesis Tony Ng, G. D. Robson, David W. Denning Microbiology Fungal Cell BiologyImmunologyClinical MycologyGlucocorticoidInflammation	1994	214
COVID‐19‐associated pulmonary aspergillosis (CAPA) in patients admitted with severe COVID‐19 pneumonia: An observational study from Pakistan Nosheen Nasir, Joveria Farooqi, Syed Faisal Mahmood, Mycoses	2020	189

Page 1